Our collaboration with startups is uniquely tailored to the specific needs of each venture, allowing for a variety of approaches.
In this episode of ROXWorX, we elaborate on our strategic partnership with theblood where ROX provides financial and non-financial support. Why and how? Listen to Dr. Olivier Flückiger, one our our ROX Co-Founders, Miriam Santer, Co-Founder of theblood and Dr. Markus Schmid, Partnering Technology & Science Lead at #Roche Diagnostics. They all share the vision to bridge the data gap in women’s health.
The blood provides at-home testing for menstrual blood and seeks to analyze it not only for hormonal or vitamin status but also for the early detection of chronic diseases such as #endometriosis. In that context, ROX shared its knowledge and expertise on how to set up and run scientific studies.
And why does non-invasive blood testing matter to Roche?
Early detection and disease prevention are becoming more and more important. Embracing novel methods in in vitro diagnostics (IVD) testing not only enhances patient accessibility but also generates more comprehensive longitudinal data, potentially uncovering new biomarkers.
Together, we’re not just reimagining healthcare – we’re reshaping it!
